| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 09/10/2008 | CN101259098A Long-acting low molecule heparin intraocular sustained-release system |
| 09/10/2008 | CN100417659C Nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 09/10/2008 | CN100417399C Eye drops with capillary artemisia, cape jasmine and baikal skullcap root, and its preparing method |
| 09/10/2008 | CN100417383C Effervescent tablet containing cefixime and its preparing method |
| 09/09/2008 | US7423177 Carboxamide derivatives as therapeutic agents |
| 09/09/2008 | US7423057 Dihydroorotate dehydrogenase (DHODH) inhibitors; Rheumatoid arthritis, Pneumocystis carinii, fibrosis, uveitis, rhinitis, asthma, and athropathy; 2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid |
| 09/09/2008 | US7423055 e.g., 2-(2-methyl-5-amino)phenyl-4-(3-pyridyl)-thiazole; c-kit inhibitors; treating cell proliferative, metabolic, allergic, and degenerative disorders. |
| 09/09/2008 | US7423020 Therapy for behavior disorders; quantitative analysis; measuring binding |
| 09/09/2008 | US7422877 Activatable recombinant neurotoxins |
| 09/09/2008 | US7422742 Gene therapy using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders, administering antibody or antigen-binding fragment thereof that specifically binds IL-5 |
| 09/09/2008 | CA2323086C Regulation of endogenous gene expression in cells using zinc finger proteins |
| 09/04/2008 | WO2008106102A2 Inhibitors of rtp801 and their use in disease treatment |
| 09/04/2008 | WO2008105454A1 Cell capable of expressing lacritin at high level |
| 09/04/2008 | WO2008105442A1 Sulfonamide derivative |
| 09/04/2008 | WO2008105408A1 Novel pyrrole derivative having ureide group and aminocarbonyl group as substituents |
| 09/04/2008 | WO2008105392A1 3-amino-2-indolylbutyrolactam derivative, process for production of the same, and pharmaceutical agent comprising the same as active ingredient |
| 09/04/2008 | WO2008105058A1 Sulfonamides |
| 09/04/2008 | WO2008104976A1 Amphipathic carboxylates for the treatment of immune-related disorders |
| 09/04/2008 | WO2008104856A2 A synergistic herbal ophthalmic formulation for lowering the intra ocular pressure in case of glaucoma |
| 09/04/2008 | WO2008104124A1 Screening method of combination pharmaceuticals, pharmaceuticals obtained by the method and uses thereof |
| 09/04/2008 | WO2008055206A3 Humanized anti-factor d antibodies |
| 09/04/2008 | US20080214781 Botulinum neurotoxin type E having increased biological half-life for use treatment and prevention of autonomic, neuromuscular and pain disorders |
| 09/04/2008 | US20080214614 reduces intraocular pressure; primary open-angle glaucoma; effective to influence the actomyosin interactions by leading to cellular relaxation and alterations in cell-substratum adhesions |
| 09/04/2008 | US20080214540 3-[(phenyl or benzothiazol-2-yl)methyl]indole-N-acetic acids and esters; analgesics; aldose reductase inhibitors; diabetes complications including cataracts, retinopathy, nephropathy, and neuropathy; side effect reduction |
| 09/04/2008 | US20080214513 Method of treating middle ear infections |
| 09/04/2008 | US20080214510 Treating patient having meibomian gland disease, aqueous tear deficiency, delayed tear clearance or recurrent comeal epithelial erosion by topically administering an effective amount of tetracycline or derivative to eye |
| 09/04/2008 | US20080214486 RNAi-MEDIATED INHIBITION OF AQUAPORIN 4 FOR TREATMENT OF IOP-RELATED CONDITIONS |
| 09/04/2008 | US20080214434 Administering high density lipoprotein |
| 09/04/2008 | US20080213776 Method for treating autoimmune diseases and screening method for preventive or therapeutic agent for the same |
| 09/04/2008 | US20080213351 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
| 09/04/2008 | US20080213324 Amphiphilic or lipophilic polar functionalized fullerenes and their uses |
| 09/04/2008 | US20080213315 free of non-300 kD botulinum toxin type A complexes |
| 09/04/2008 | US20080213274 Compositions and methods for the treatment and prevention of fibrotic, inflammatory, and neovascularization conditions of the eye |
| 09/04/2008 | US20080213219 Methods for treatment and management of macular degeneration using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 09/04/2008 | US20080213188 Novel ophthalmic compositions containing human recombinant lysozyme and use thereof for treating eye conditions and as contact lens solutions |
| 09/04/2008 | CA2679263A1 Sulfonamide compound |
| 09/04/2008 | CA2678735A1 Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents |
| 09/03/2008 | EP1964845A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/03/2008 | EP1964844A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/03/2008 | EP1964575A1 Pharmaceutical comprising ppar agonist |
| 09/03/2008 | EP1963280A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
| 09/03/2008 | EP1962857A2 Use of anecortave acetate as an adjunct during filtration bleb surgery |
| 09/03/2008 | EP1962825A2 Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage |
| 09/03/2008 | EP1465626B1 Pharmaceutical compositions (kit) comprising dihydropyridinone compounds and an immunoregulatory (or an antiinflammatory) agent and their uses |
| 09/03/2008 | EP1343781B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/03/2008 | EP1253943B1 Photodynamic therapy for treating conditions of the eye |
| 09/03/2008 | EP1126869B1 Methods for regulating angiogenesis and vascular integrity using the trk receptor ligands bdnf, nt-3 and nt-4 |
| 09/03/2008 | CN101258156A Amorphous and crystalline forms of dorzolamide hydrochloride and processes of making same |
| 09/03/2008 | CN101257915A Method of inhibiting angiogenesis by using ephrin B2 |
| 09/03/2008 | CN101257899A Treatment of autoimmune diseases |
| 09/03/2008 | CN100415895C Non-splicing variant of gp 350/220 |
| 09/03/2008 | CN100415747C Phosphodiesterase 4 inhibitors |
| 09/03/2008 | CN100415718C CASPASE inhibitors and use thereof |
| 09/03/2008 | CN100415285C Zijing liver tonifying pill |
| 09/03/2008 | CN100415227C Use of compounds in preparing medicament for treating treating transplant rejection |
| 09/02/2008 | US7420061 Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 09/02/2008 | US7420042 Soluble neuropilin/growth factor receptor fusion proteins |
| 09/02/2008 | US7419999 Gamma lactams as prostaglandin agonists and use thereof |
| 09/02/2008 | US7419998 Therapeutic methods and compositions involving isoflavones |
| 09/02/2008 | US7419994 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2- thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cyloalkenylmethyl) imidazol-2-ones and related compounds |
| 09/02/2008 | US7419987 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them |
| 09/02/2008 | US7419676 Activatable recombinant neurotoxins |
| 09/02/2008 | US7419672 Genes and proteins, and their use |
| 09/02/2008 | CA2372053C Compositions and methods for cancer treatment by selectively inhibiting vegf |
| 09/02/2008 | CA2293325C 8-iso-prostaglandins for glaucoma therapy |
| 09/02/2008 | CA2146973C Uses of tgf-.beta. receptor fragment as a therapeutic agent |
| 08/28/2008 | WO2008103847A2 Bridged polycyclic compound based compositions for the inhibition and amelioration of disease |
| 08/28/2008 | WO2008103636A1 Imidazoquinolines as dual lipid kinase and mtor inhibitors |
| 08/28/2008 | WO2008103301A2 Treatment of the eye using macrophages and/or agents able to affect blood vessel morphology |
| 08/28/2008 | WO2008102790A1 Pharmaceutical composition for prevention or treatment of disease associated with tear reduction |
| 08/28/2008 | WO2008102777A1 Ameliorating agent for insulin resistance |
| 08/28/2008 | WO2008060787A3 Methods for treatment of cochlear and vestibular disorders |
| 08/28/2008 | US20080207753 Antiinflammatory agents; cardiovascular disorders; vision defects; skin disorders; central nervous system disorders; antiarthritic agents |
| 08/28/2008 | US20080207739 Sphingosine phosphate receptor antagonist |
| 08/28/2008 | US20080207699 Pyrazole Derivatives |
| 08/28/2008 | US20080207692 Vision defects; mixture includes source of hydrogen peroxide |
| 08/28/2008 | US20080207680 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents |
| 08/28/2008 | US20080207647 Pyrazole Derivatives Having Tyrosine Kinase Activity |
| 08/28/2008 | US20080207642 Respiratory system disorders; asthma; chronic obstructive pulmonary diseases; autoimmune diseases; antiproliferative agents; anticancer agents |
| 08/28/2008 | US20080207623 Peptide-enhanced corneal drug delivery |
| 08/28/2008 | US20080207572 Administering 2-aminoarylthiazole or 2-aminoaryloxazole derivative to treat relapsed or refractory multiple myeloma expressing FGFR3 (fibroblast growth factor receptor) |
| 08/28/2008 | US20080207502 Anti-Angiogenic Peptides and Methods of Use Thereof |
| 08/28/2008 | US20080207499 Rage-related methods for treating and preventing diabetic retinopathy |
| 08/28/2008 | US20080207495 therapeutic methods, compositions, and medicaments related to cyclosporine. |
| 08/28/2008 | US20080207494 Cyclosporin Compositions |
| 08/28/2008 | US20080206267 Inactivation Of Genes Of The Mep Pathway |
| 08/28/2008 | US20080206263 Methods and Compositions for Prognosing, Detecting, and Treating Age-Related Macular Degeneration |
| 08/28/2008 | US20080206257 Reducing epithelial toxicity during cancer therapy by administering KGF with e.g. erlotinib, Iressa(TM), canertinib, or a monoclonal antibody against EGFR; side effect reduction of diarrhea, rash |
| 08/28/2008 | US20080206228 Medicament for topical use containing hyaluronic acid and proteolytic enzyme collagenase for use as wound healing agent |
| 08/28/2008 | CA2678757A1 Ameliorating agent for insulin resistance |
| 08/28/2008 | CA2677582A1 Pharmaceutical composition for prevention or treatment of disease associated with tear reduction |
| 08/28/2008 | CA2676786A1 Imidazoquinolines as dual lipid kinase and mtor inhibitors |
| 08/27/2008 | EP1960353A2 Prostaglandins and analogues as agents for lowering intraocular pressure |
| 08/27/2008 | EP1959949A2 Control of intraocular pressure using alk5 modulation agents |
| 08/27/2008 | EP1337560B1 Truncated cd200 |
| 08/27/2008 | EP1337262B1 Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
| 08/27/2008 | EP1313714B1 Valsartan salts |
| 08/27/2008 | EP1089994B9 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same |
| 08/27/2008 | CN101253166A Sulfonamide compound |
| 08/27/2008 | CN101252952A Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid |